PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers
Year: 2009
Type: article
Source: Cancer Research
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funders: Sanofi, National Cancer Institute
OpenAlex ID: W2120492882
